Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia

Simple item page
dc.creatorMahmound, R.A.K.
dc.creatorAbdel Raouf, M.
dc.date2014-06-17T07:41:31Z
dc.date2014-06-17T07:41:31Z
dc.date2006-12-31
dc.date.accessioned2026-08-03T11:16:27Z
dc.description178-187
dc.descriptionWe evaluated the prognostic value of serum endostatin and vascular endothelial growth factor [VEGF] for diagnosis of pre-eclampsia. We determined VEGF and endostatin levels in the sera of 20 healthy, non-pregnant women and 64 pregnant women: 20 healthy, 20 with mild pre-eclampsia and 24 with severe pre-eclampsia. Serum levels of these factors in non-pregnant women were similar to those in healthy pregnant women. However, serum levels were significantly higher with mild or severe pre-eclampsia compared with normal pregnancies and significantly higher with severe rather than with mild pre-eclampsia. Elevated levels significantly increased risk more than severity of pre-eclampsia. VEGF and endostatin could be used to differentiate between pre-eclamptic and normal pregnancies and to discriminate mild pre-eclampsia from severe pre-eclampsia
dc.formatapplication/pdf
dc.identifier1020-3397
dc.identifierhttp://applications.emro.who.int/emhj/1201_2/12_1-2_2006_178_187.pdf
dc.identifierhttps://iris.who.int/handle/10665/117069
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/244539
dc.languageEnglish
dc.languageen
dc.relationEMHJ - Eastern Mediterranean Health Journal, 12 (1-2), 178-187, 2006
dc.subjectPre-Eclampsia
dc.subjectEndothelial Growth Factors
dc.subjectVascular Endothelial Growth Factor A
dc.subjectPregnancy
dc.subjectPre-Eclampsia
dc.titleSerum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia

Files

Collections

WHO IRIS